It seems to me the biggest threat to the prospects of the company is trial failure of some kind or competing technology. I recently saw the following article https://www.dailymail.co.uk/sciencetech/article-8435753/Finger-prick-blood-test-revolutionise-cancer-treatment.html. Could someone knowledgeable on the science comment on this, is this a competing technology and of concern to investors in IBX?
